Today: 30 April 2026
Adidas stock tumbles on BofA double-downgrade as investors reassess growth runway
6 January 2026
1 min read

Adidas stock tumbles on BofA double-downgrade as investors reassess growth runway

Frankfurt, Jan 6, 2026, 14:39 CET — Regular session

  • Adidas shares fall about 6% after Bank of America cuts the stock to “underperform” and slashes its target to €160
  • BofA flags slowing “organic” growth and fading margin tailwinds across the sporting-goods sector
  • Investors look to upcoming macro data and Adidas’ FY 2025 results for the next catalyst

Adidas shares slid on Tuesday after Bank of America double-downgraded the German sportswear maker, souring sentiment across a sector that had relied on a steady stream of earnings upgrades. The stock was down 5.5% at 160.48 euros, with trading volume running above its three-month average.

The call matters because Adidas has been pitched as a turnaround with improving demand and pricing power, a view that helped support the stock even as consumer spending stayed uneven in parts of Europe. A two-notch cut from a major broker forces investors to re-test those assumptions in real time.

It also lands as equity markets start the year near record levels, leaving less room for missteps in stocks that trade on growth expectations. For Adidas, the key debate now is whether sales momentum and margins can keep improving once one-off boosts fade.

Bank of America argued that the “upcycle” story had become well known and had “stopped leading to EPS upgrades” in recent quarters, in a note led by analyst Thierry Cota. The broker said it now expects Adidas to settle into single-digit organic sales growth — sales growth excluding currency swings and acquisitions — with the operating margin (EBIT margin) reverting closer to longer-run averages, and it cut its 2027 earnings forecast by 7%. Investing.com

BofA also cut its price target to 160 euros from 213 euros and downgraded JD Sports, warning that a two-decade “casualisation” trend — the shift toward sneakers and athletic wear in everyday wardrobes — is largely complete. The broker said a weaker growth backdrop could push investors toward names it views as having more durable growth, while competition remains intense. Sharecast

The move stood out even as European stocks edged higher and Germany’s DAX flirted with record levels, with traders focused on a heavy slate of inflation figures and manufacturing readings that could shape rate-cut expectations. Those macro signals matter for consumer-facing stocks because easier policy can lift valuations, while sticky inflation can keep pressure on household spending.

Still, the downgrade is not the only possible path for the stock. Bank of America said the 2026 FIFA World Cup could provide a demand boost, but warned growth may moderate after that, and it flagged Nike’s turnaround as a competitive threat as shoppers weigh rival brands.

For now, traders are watching whether the shares stabilise after the sharp drop and whether other brokers follow with rating or target changes. Investors also want clearer signals on promotions and inventory levels, which can quickly erode margins in apparel when demand cools.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
AMD stock slips in premarket as CES AI-chip push puts OpenAI ramp in spotlight
Previous Story

AMD stock slips in premarket as CES AI-chip push puts OpenAI ramp in spotlight

Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts
Next Story

Dow Jones today: DIA stock steadies near record as Fed’s Miran backs big rate cuts

Go toTop